iSTAR Medical Announces First Patient Implanted with STARflo Glaucoma Drainage Device in European Clinical Trial
Isnes, Belgium: 30 October 2014 - iSTAR Medical SA, a privately held ophthalmic device company, announced today that the first patient in its European multi-center clinical trial has been successfully implanted with the STARfloTM glaucoma drainage device.
The study will be conducted at leading clinical study sites across Europe to evaluate the effectiveness and safety of the STARfloTM system in patients with Open-angle glaucoma and is designed to support broader adoption of STARfloTM in geographies where it has been approved. STARflo received European CE Mark approval in 2012 and is currently available through distributors in select countries.
More info on iSTAR Medical's website.
Next > Nexstim Plc successfully completes its Initial Public Offering - subscriptions reach 15.3 million with final offer price of 6.35 per share
Previous > FPIM invests 5 million in Capricorn ICT Arkiv